Operating Cash Flow (Statement)

€1.69B

TTM · Period ending: Jun 30, 2026 · EUR

Latest reported€1.69B EURperiod endingJun 30, 2026

BMXMF TTM Cash from Operations · EUR (€538.80M → €1.69B)

TTM operating cash flow (statement)

High-resolution chart · PNG

BMXMF operating cash flow (statement) history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

bioMérieux S.A. Operating Cash Flow (Statement) — Trailing twelve months (TTM) (EUR)
Period ending	Operating Cash Flow (Statement) (EUR)
Jun 30, 2026	1,694,469,802
Dec 31, 2025	1,455,423,667
Jun 30, 2025	1,282,300,000
Dec 31, 2024	1,112,700,000
Jun 30, 2024	966,700,000
Dec 31, 2023	920,500,000
Jun 30, 2023	1,148,300,000
Dec 31, 2022	1,286,200,000
Jun 30, 2022	1,284,100,000
Dec 31, 2021	1,393,900,000
Jun 30, 2021	1,101,200,000
Dec 31, 2020	990,700,000
Jun 30, 2020	924,100,000
Dec 31, 2019	807,700,000
Jun 30, 2019	771,000,000
Dec 31, 2018	741,100,000
Jun 30, 2018	679,500,000
Dec 31, 2017	676,900,000
Jun 30, 2017	681,400,000
Dec 31, 2016	645,600,000
Jun 30, 2016	642,900,000
Dec 31, 2015	608,300,000
Jun 30, 2015	546,700,000
Dec 31, 2014	538,800,000